Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.5 USD | +0.97% | +4.29% | +9.39% |
06:14pm | US CDC warns of harmful reactions to fake Botox injections | RE |
Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.39% | 297B | |
+27.92% | 659B | |
+27.68% | 557B | |
-4.59% | 359B | |
+16.38% | 322B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.58% | 149B | |
-4.99% | 146B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Seeks European Approval for Risankizumab in Moderate to Severe Crohn's Disease